Results     20-May-25
Announcements
Zydus Lifesciences consolidated net profit declines 0.96% in the March 2025 quarter
Sales rise 17.21% to Rs 6290.20 crore
Net profit of Zydus Lifesciences declined 0.96% to Rs 1170.90 crore in the quarter ended March 2025 as against Rs 1182.30 crore during the previous quarter ended March 2024. Sales rose 17.21% to Rs 6290.20 crore in the quarter ended March 2025 as against Rs 5366.40 crore during the previous quarter ended March 2024.

For the full year,net profit rose 17.26% to Rs 4525.50 crore in the year ended March 2025 as against Rs 3859.50 crore during the previous year ended March 2024. Sales rose 18.68% to Rs 22573.80 crore in the year ended March 2025 as against Rs 19021.50 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales6290.205366.40 17 22573.8019021.50 19
OPM %33.7930.38 -31.2728.31 -
PBDT2129.501752.30 22 7162.105587.20 28
PBT1891.601547.00 22 6246.304823.10 30
NP1170.901182.30 -1 4525.503859.50 17

Previous News
  Zydus Life subsidiary ZHL appoints Swati Dalal as MD
 ( Hot Pursuit - 16-Jun-25   14:42 )
  Zydus Lifesciences appoints Managing Director
 ( Corporate News - 16-Jun-25   14:16 )
  Zydus' Ankleshwar API unit clears USFDA inspection
 ( Corporate News - 12-Jun-25   10:41 )
  Zydus Life receives USFDA EIR for Gujarat facility
 ( Hot Pursuit - 12-Jun-25   09:55 )
  Zydus Life receives USFDA EIR for Dabhasa API facility
 ( Hot Pursuit - 10-Jun-25   15:19 )
  Zydus receives EIR for the API manufacturing facility at Dabhasa
 ( Corporate News - 10-Jun-25   14:11 )
  Zydus Lifesciences Ltd spurts 0.24%, up for fifth straight session
 ( Hot Pursuit - 10-Jun-25   13:00 )
  Stock Alert: Yes Bank, Zydus Lifesciences, Ashok Leyland, R Systems Intl
 ( Market Commentary - Stock Alert 04-Jun-25   08:05 )
  Zydus Lifesciences gets USFDA nod for Rifaximin tablets
 ( Hot Pursuit - 02-Jun-25   10:47 )
  Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets
 ( Corporate News - 02-Jun-25   09:12 )
  Zydus Lifesciences’ Usnoflast receives USFDA fast track designation for ALS Treatment
 ( Hot Pursuit - 28-May-25   13:23 )
Other Stories
  Orissa Minerals Development Company reports standalone net loss of Rs 31.44 crore in the March 2025 quarter
  18-Jun-25   07:29
  Dhelakhat Tea Co reports standalone net loss of Rs 3.11 crore in the March 2025 quarter
  18-Jun-25   07:29
  Kant & Company reports standalone net loss of Rs 0.12 crore in the March 2025 quarter
  18-Jun-25   07:29
  Indo Eco (India) reports standalone net profit of Rs 0.01 crore in the March 2025 quarter
  18-Jun-25   07:29
  Purshottam Investofin reports standalone net loss of Rs 0.91 crore in the March 2025 quarter
  18-Jun-25   07:29
  Indrayani Biotech reports consolidated net loss of Rs 5.81 crore in the March 2025 quarter
  17-Jun-25   07:29
  Vipul reports consolidated net loss of Rs 34.95 crore in the March 2025 quarter
  17-Jun-25   07:29
  Adarsh Mercantile reports consolidated net profit of Rs 2.60 crore in the March 2025 quarter
  17-Jun-25   07:29
  Belrise Industries consolidated net profit rises 574.56% in the March 2025 quarter
  16-Jun-25   12:37
  K&R Rail Engineering reports consolidated net loss of Rs 8.35 crore in the March 2025 quarter
  16-Jun-25   07:29
Back Top